Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jianlin Wang, Haimin Li, Congcong Xia, Xisheng Yang, Bin Dai, Kaishan Tao & Kefeng Dou. (2019) Downregulation of CENPK suppresses hepatocellular carcinoma malignant progression through regulating YAP1. OncoTargets and Therapy 12, pages 869-882.
Read now
Read now
Xiaofei Xu, Yan Chen, Xi Wang & Xingguo Mu. (2019) Role of Hippo/YAP signaling in irradiation-induced glioma cell apoptosis. Cancer Management and Research 11, pages 7577-7585.
Read now
Read now
Jia Zhao, Xiangnan Li, Yang Yang, Dengyan Zhu, Chunyang Zhang, Donglei Liu, Kai Wu & Song Zhao. (2016) Effect of YAP1 silencing on esophageal cancer. OncoTargets and Therapy 9, pages 3137-3146.
Read now
Read now
Angela M Liu, Zhi Xu & John M Luk. (2012) An update on targeting Hippo-YAP signaling in liver cancer. Expert Opinion on Therapeutic Targets 16:3, pages 243-247.
Read now
Read now
Articles from other publishers (72)
Xiaomin Li, Qing Liu, Songyu Xie, Xiaoping Wu & Junsheng Fu. (2023) Mechanism of action of cordycepin in the treatment of hepatocellular carcinoma via regulation of the Hippo signaling pathway. Food Science and Human Wellness, pages 1-21.
Crossref
Crossref
Yan‐ke Li, Li‐rong Yan, Ang Wang, Li‐yue Jiang, Qian Xu & Ben‐gang Wang. (2022)
RNA
‐sequencing reveals the expression profiles of
tsRNAs
and their potential carcinogenic role in cholangiocarcinoma
. Journal of Clinical Laboratory Analysis 36:10.
Crossref
Crossref
Jiayao Feng, Shuting Qiu, Shipeng Zhou, Yue Tan, Yan Bai, Hua Cao, Jiao Guo & Zhengquan Su. (2022) mTOR: A Potential New Target in Nonalcoholic Fatty Liver Disease. International Journal of Molecular Sciences 23:16, pages 9196.
Crossref
Crossref
Teresa Garcia-Lezana, Juan Luis Lopez-Canovas & Augusto Villanueva. 2021. Mechanisms and Therapy of Liver Cancer. Mechanisms and Therapy of Liver Cancer
63
101
.
Anja Moncsek & Joachim C. Mertens. 2021. Diagnosis and Management of Cholangiocarcinoma. Diagnosis and Management of Cholangiocarcinoma
509
526
.
Xia Qian, Wei Zhang, Alireza Shams, Kahee Mohammed, Alex S. Befeler, Ningling Kang & Jinping Lai. (2020) Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization. Liver Research 4:4, pages 212-217.
Crossref
Crossref
Aijia Zhang, Weilong Wang, Zhijun Chen, Dan Pang, Xiaofeng Zhou, Kui Lu, Jinghan Hou, Sujie Wang, Can Gao, Benjie Lv, Ziyi Yan, Zhen Chen, Jian Zhu, Lidong Wang, Ting Zhuang & Xiumin Li. (2020) SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling. Neoplasia 22:2, pages 76-85.
Crossref
Crossref
Jing Wang, Tiefang Song, Suiyang Zhou & Xianchao Kong. (2019) YAP promotes the malignancy of endometrial cancer cells via regulation of IL-6 and IL-11. Molecular Medicine 25:1.
Crossref
Crossref
Chun Chen, Zhe Yang & Zan-Song Huang. (2019) Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma. World Chinese Journal of Digestology 27:21, pages 1330-1338.
Crossref
Crossref
Eman AE. Badr, Ibrahim El Tantawy El Sayed, Mohamed FA. Assar, Sahar AM. Ali & Nehal S. Ibrahim. (2019) A pilot study of Livin gene and Yes-associated protein 1 expression in hepatocellular carcinoma patients. Heliyon 5:11, pages e02798.
Crossref
Crossref
Cong Ye, Yubo Hu, Junrong Wang, Dahai Liu & Jianshi Du. (2019) Mono (2-ethylhexyl) phthalate (MEHP) triggers the proliferation of hemangioma-derived endothelial cells via YAP signals. Chemico-Biological Interactions 311, pages 108773.
Crossref
Crossref
Panpan An, Jiexin Li, Linlin Lu, Yingmin Wu, Yuyi Ling, Jun Du, Zhuojia Chen & Hongsheng Wang. (2019) Histone deacetylase 8 triggers the migration of triple negative breast cancer cells via regulation of YAP signals. European Journal of Pharmacology 845, pages 16-23.
Crossref
Crossref
Chun Feng, Yuxiao Li, Yan Lin, Xianbao Cao, Dongdong Li, Honglei Zhang & Xiaoguang He. (2018) CircRNA-associated ceRNA network reveals ErbB and Hippo signaling pathways in hypopharyngeal cancer. International Journal of Molecular Medicine.
Crossref
Crossref
Hang-Lung Chang, Hsin-An Chen, Oluwaseun Adebayo Bamodu, Kwai-Fong Lee, Yew-Min Tzeng, Wei-Hwa Lee & Jo-Ting Tsai. (2018) Ovatodiolide suppresses yes-associated protein 1-modulated cancer stem cell phenotypes in highly malignant hepatocellular carcinoma and sensitizes cancer cells to chemotherapy in vitro. Toxicology in Vitro 51, pages 74-82.
Crossref
Crossref
Yu Fang, Chun Liu, Bo Shu, Mimi Zhai, Chaolin Deng, Chao He, Ming Luo, Tong Han, Wei Zheng, Jingyao Zhang & Sushun Liu. (2018) Axis of serotonin -pERK-YAP in liver regeneration. Life Sciences 209, pages 490-497.
Crossref
Crossref
Zhize Chen, Jingjing Xu, Yang Wu, Shaoqing Lei, Huimin Liu, Qingtao Meng & Zhongyuan Xia. (2018) Diosgenin inhibited the expression of TAZ in hepatocellular carcinoma. Biochemical and Biophysical Research Communications 503:3, pages 1181-1185.
Crossref
Crossref
Zhenhai Fan, Hongwei Xia, Huanji Xu, Ji Ma, Sheng Zhou, Wanting Hou, Qiulin Tang, Qiyong Gong, Yongzhan Nie & Feng Bi. (2018) Standard CD44 modulates YAP1 through a positive feedback loop in hepatocellular carcinoma. Biomedicine & Pharmacotherapy 103, pages 147-156.
Crossref
Crossref
Han-Byul Kim & Seung-Jae Myung. (2018) Clinical implications of the Hippo-YAP pathway in multiple cancer contexts. BMB Reports 51:3, pages 119-125.
Crossref
Crossref
Chunlin Ou, Zhenqiang Sun, Shen Li, Guiyuan Li, Xiayu Li & Jian Ma. (2017) Dual roles of yes-associated protein (YAP) in colorectal cancer. Oncotarget 8:43, pages 75727-75741.
Crossref
Crossref
Liang Shan, Hongyuan Jiang, Lifang Ma & Yongchun Yu. (2017) Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma. Oncology Letters 14:3, pages 3291-3296.
Crossref
Crossref
Lijuan Song, Hongbo Tang, Wenjing Liao, Xinggu Luo, Yanmei Li, Tao Chen & Xiaowen Zhang. (2017) FOXC2 positively regulates YAP signaling and promotes the glycolysis of nasopharyngeal carcinoma. Experimental Cell Research 357:1, pages 17-24.
Crossref
Crossref
Ting‐Huan Chen, Chen‐Yu Chen, Hui‐Chin Wen, Chia‐Chu Chang, Horng‐Dar Wang, Chih‐Pin Chuu & Chung‐Ho Chang. (2017) YAP promotes myogenic differentiation via the MEK5‐ERK5 pathway. The FASEB Journal 31:7, pages 2963-2972.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
2987
3006
.
Yuzhuo Wu, Junhe Zhang, Huaihong Zhang & Yufeng Zhai. (2016) Hepatitis B virus X protein mediates yes-associated protein 1 upregulation in hepatocellular carcinoma. Oncology Letters 12:3, pages 1971-1974.
Crossref
Crossref
Chiara Lazzari, Alberto Verlicchi, Anastasios Gkountakos, Sara Pilotto, Mariacarmela Santarpia, Imane Chaib, Jose Luis Ramirez Serrano, Santiago Viteri, Daniela Morales-Espinosa, Claudio Dazzi, Filippo de Marinis, Peng Cao, Niki Karachaliou & Rafael Rosell. (2016) Molecular Bases for Combinatorial Treatment Strategies in Patients with KRAS Mutant Lung Adenocarcinoma and Squamous Cell Lung Carcinoma. Pulmonary Therapy 2:1, pages 1-18.
Crossref
Crossref
Mingjing He, Zhuan Zhou, Anil A. Shah, Yang Hong, Qianming Chen & Yong Wan. (2016) New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics. Cell Division 11:1.
Crossref
Crossref
Xiao-Yang Dai, Lin-Han Zhuang, Dan-Dan Wang, Tian-Yi Zhou, Lin-Lin Chang, Ren-Hua Gai, Di-Feng Zhu, Bo Yang, Hong Zhu & Qiao-Jun He. (2016) Nuclear translocation and activation of YAP by hypoxia contributes to the chemoresistance of SN38 in hepatocellular carcinoma cells. Oncotarget 7:6, pages 6933-6947.
Crossref
Crossref
Cameron L. Noland, Sarah Gierke, Paul D. Schnier, Jeremy Murray, Wendy N. Sandoval, Meredith Sagolla, Anwesha Dey, Rami N. Hannoush, Wayne J. Fairbrother & Christian N. Cunningham. (2016) Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling. Structure 24:1, pages 179-186.
Crossref
Crossref
Zhihua Qiu, Wen Yuan, Tao Chen, Chenzhi Zhou, Chao Liu, Yongkai Huang, Deqing Han & Qinghui Huang. (2016) HMGCR positively regulated the growth and migration of glioblastoma cells. Gene 576:1, pages 22-27.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
20
.
Thomas Bertero, Katherine A. Cottrill, Sofia Annis, Balkrishen Bhat, Bernadette R. Gochuico, Juan C. Osorio, Ivan Rosas, Kathleen J. Haley, Kathleen E. Corey, Raymond T. Chung, B. Nelson Chau & Stephen Y. Chan. (2015) A YAP/TAZ-miR-130/301 molecular circuit exerts systems-level control of fibrosis in a network of human diseases and physiologic conditions. Scientific Reports 5:1.
Crossref
Crossref
Yan Guo, Qiao Pan, Jing Zhang, Xinyuan Xu, Xiping Liu, Qinhao Wang, Ru Yi, Xiaobo Xie, Libo Yao, Wenchao Liu & Lan Shen. (2015) Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma. Journal of Cellular Biochemistry 116:11, pages 2465-2475.
Crossref
Crossref
Matthew T. Simpson, Ishwariya Venkatesh, Ben L. Callif, Laura K. Thiel, Denise M. Coley, Kristen N. Winsor, Zimei Wang, Audra A. Kramer, Jessica K. Lerch & Murray G. Blackmore. (2015) The tumor suppressor HHEX inhibits axon growth when prematurely expressed in developing central nervous system neurons. Molecular and Cellular Neuroscience 68, pages 272-283.
Crossref
Crossref
Tiemin Pei, Yuejin Li, Jiabei Wang, Huanlai Wang, Yingjian Liang, Huawen Shi, Boshi Sun, Dalong Yin, Jing Sun, Ruipeng Song, Shangha Pan, Yu Sun, Hongchi Jiang, Tongsen Zheng & Lianxin Liu. (2015) YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget 6:19, pages 17206-17220.
Crossref
Crossref
Chang-Jiang Lei, Lei Li, Xia Gao, Jun Zhang, Qing-Yun Pan, Hao-Cheng Long, Chun-Zhou Chen, De-Fa Ren & Gang Zheng. (2015) Hsa-miR-132 inhibits proliferation of hepatic carcinoma cells by targeting YAP. Cell Biochemistry and Function 33:5, pages 326-333.
Crossref
Crossref
Guosheng Tan, Xinping Cao, Qiangsheng Dai, Bing Zhang, Jianwen Huang, Shiqiu Xiong, Yong yu Zhang, Wei Chen, Jianyong Yang & Heping Li. (2015) A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ. Oncotarget 6:11, pages 8676-8686.
Crossref
Crossref
Yuen Gao, Yuan Wang, Jinyan Feng, Guoxing Feng, Minying Zheng, Zhe Yang, Zelin Xiao, Zhanping Lu, Lihong Ye & Xiaodong Zhang. (2015) A hairpin within YAP mRNA 3′UTR functions in regulation at post-transcription level. Biochemical and Biophysical Research Communications 459:2, pages 306-312.
Crossref
Crossref
Zheng Zhou, Taishan Hu, Zhiheng Xu, Zhaohu Lin, Zhisen Zhang, Teng Feng, Liangcheng Zhu, Yiping Rong, Hong Shen, John M. Luk, Xiongwen Zhang & Ning Qin. (2014) Targeting Hippo pathway by specific interruption of YAP‐TEAD interaction using cyclic YAP‐like peptides. The FASEB Journal 29:2, pages 724-732.
Crossref
Crossref
Michele T. Pritchard & Udayan Apte. 2015. Liver Regeneration. Liver Regeneration
15
40
.
Kangsheng Tu, Wei Yang, Chao Li, Xin Zheng, Zhongtang Lu, Cheng Guo, Yingmin Yao & Qingguang Liu. (2014) Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma. Molecular Cancer 13:1.
Crossref
Crossref
Maolan Li, Jianhua Lu, Fei Zhang, Huaifeng Li, Bingtai Zhang, Xiangsong Wu, Zhujun Tan, Lin Zhang, Guofeng Gao, Jiasheng Mu, Yijun Shu, Runfa Bao, Qichen Ding, Wenguang Wu, Ping Dong, Jun Gu & Yingbin Liu. (2014) Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway. Cancer Letters 355:2, pages 201-209.
Crossref
Crossref
Libo Yan, Qingchun Cai & Yan Xu. (2014) Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Archives of Biochemistry and Biophysics 562, pages 31-36.
Crossref
Crossref
Zhisen Zhang, Zhaohu Lin, Zheng Zhou, Hong C. Shen, S. Frank Yan, Alexander V. Mayweg, Zhiheng Xu, Ning Qin, Jason C. Wong, Zhenshan Zhang, Yiping Rong, David C. Fry & Taishan Hu. (2014) Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein Interaction. ACS Medicinal Chemistry Letters 5:9, pages 993-998.
Crossref
Crossref
Hermann AM Mucke. (2014) Patent Highlights. Pharmaceutical Patent Analyst 3:5, pages 485-490.
Crossref
Crossref
Grzegorz T. Gurda, Qingfeng Zhu, Haibo Bai, Duojia Pan, Kathleen B. Schwarz & Robert A. Anders. (2014) The use of Yes-associated protein expression in the diagnosis of persistent neonatal cholestatic liver disease. Human Pathology 45:5, pages 1057-1064.
Crossref
Crossref
Randy Johnson & Georg Halder. (2013) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nature Reviews Drug Discovery 13:1, pages 63-79.
Crossref
Crossref
Milton J. Finegold & Dolores H. López-Terrada. 2014. Pathology of Pediatric Gastrointestinal and Liver Disease. Pathology of Pediatric Gastrointestinal and Liver Disease
547
614
.
Peng Li, Ying Chen, Kinglun Kingston Mak, Chun Kwok Wong, Chi Chiu Wang & Ping Yuan. (2013) Functional Role of Mst1/Mst2 in Embryonic Stem Cell Differentiation. PLoS ONE 8:11, pages e79867.
Crossref
Crossref
Gi Jeong Kim, Hyunki Kim & Young Nyun Park. (2013) Increased Expression of Yes-Associated Protein 1 in Hepatocellular Carcinoma with Stemness and Combined Hepatocellular-Cholangiocarcinoma. PLoS ONE 8:9, pages e75449.
Crossref
Crossref
C M Xu, W W Liu, C J Liu, C Wen, H F Lu & F S Wan. (2013) Mst1 overexpression inhibited the growth of human non-small cell lung cancer in vitro and in vivo. Cancer Gene Therapy 20:8, pages 453-460.
Crossref
Crossref
S E Lee, J U Lee, M H Lee, M J Ryu, S J Kim, Y K Kim, M J Choi, K S Kim, J M Kim, J W Kim, Y W Koh, D-S Lim, Y S Jo & M Shong. (2013) RAF kinase inhibitor-independent constitutive activation of Yes-associated protein 1 promotes tumor progression in thyroid cancer. Oncogenesis 2:7, pages e55-e55.
Crossref
Crossref
Ling Yang, Sayaka Inokuchi, Yoon Seok Roh, Jingyi Song, Rohit Loomba, Eek Joong Park & Ekihiro Seki. (2013) Transforming Growth Factor–β Signaling in Hepatocytes Promotes Hepatic Fibrosis and Carcinogenesis in Mice With Hepatocyte-Specific Deletion of TAK1. Gastroenterology 144:5, pages 1042-1054.e4.
Crossref
Crossref
Chuanming Xu, Chunju Liu, Wei Huang, Shuo Tu & Fusheng Wan. (2013) Effect of <italic>Mst1</italic> overexpression on the growth of human hepatocellular carcinoma HepG2 cells and the sensitivity to cisplatin <italic>in vitro</italic>. Acta Biochimica et Biophysica Sinica 45:4, pages 268-279.
Crossref
Crossref
Hui-Lai Miao, Zhi-Jian Pan, Chang-Jiang Lei, Ji-Yu Wen, Ming-Yi Li, Zhong-Kao Liu, Zhi-Dong Qiu, Man-Zhou Lin, Nian-Ping Chen & Ming Chen. (2013) Knockdown of GPC3 inhibits the proliferation of Huh7 hepatocellular carcinoma cells through down-regulation of YAP. Journal of Cellular Biochemistry 114:3, pages 625-631.
Crossref
Crossref
J. Zhang, J-S. Zhu, Y-C. Yang, Z. Zhou, W-X. Chen & N-W. Chen. (2013) Enhancing the Therapeutic Effects of Ethyl Pyruvate on Gastric Cancer through Knockdown of YAP1 Expression. European Journal of Inflammation 11:1, pages 123-132.
Crossref
Crossref
Tao Zhang, Junping Zhang, Xiaona You, Qian Liu, Yumei Du, Yuen Gao, Changliang Shan, Guangyao Kong, Youliang Wang, Xiao Yang, Lihong Ye & Xiaodong Zhang. (2012) Hepatitis B virus X protein modulates oncogene yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology 56:6, pages 2051-2059.
Crossref
Crossref
J. Zhang, Y-C. Yang, J-S. Zhu, Z. Zhou & W-X. Chen. (2012) Clinicopathologic Characteristics and Yes-Associated Protein 1 Overexpression and its Relationship to Tumor Biomarkers in Gastric Cancer. International Journal of Immunopathology and Pharmacology 25:4, pages 977-987.
Crossref
Crossref
Rafael RosellRafael Rosell. 2012. Molecular-Based Decision Making for Personalized Cancer Management. Molecular-Based Decision Making for Personalized Cancer Management
50
73
.
Rafael RosellRafael Rosell. 2012. Molecular-Based Decision Making for Personalized Cancer Management. Molecular-Based Decision Making for Personalized Cancer Management
114
135
.
Rafael RosellRafael Rosell. 2012. Molecular-Based Decision Making for Personalized Cancer Management. Molecular-Based Decision Making for Personalized Cancer Management
90
112
.
Rafael RosellRafael Rosell. 2012. Molecular-Based Decision Making for Personalized Cancer Management. Molecular-Based Decision Making for Personalized Cancer Management
6
26
.
Wenqi Wang, Jun Huang, Xin Wang, Jingsong Yuan, Xu Li, Lin Feng, Jae-Il Park & Junjie Chen. (2012) PTPN14 is required for the density-dependent control of YAP1. Genes & Development 26:17, pages 1959-1971.
Crossref
Crossref
J. Zhang, Z-P. Xu, Y-C. Yang, J-S. Zhu, Z. Zhou & W-X. Chen. (2012) Expression and Yes-Associated Protein in Gastric Adenocarcinoma and Inhibitory Effects of its Knockdown on Gastric Cancer Cell Proliferation and Metastasis. International Journal of Immunopathology and Pharmacology 25:3, pages 583-590.
Crossref
Crossref
Chuan-Ming XU & Fu-Sheng WAN. (2012) Hippo signaling pathway in mammals：a new therapeutic target for tumors. Hereditas (Beijing) 34:3, pages 269-280.
Crossref
Crossref
Caroline H. Diep, Kelly M. Zucker, Galen Hostetter, Aprill Watanabe, Chengcheng Hu, Ruben M. Munoz, Daniel D. Von Hoff & Haiyong Han. (2012) Down-Regulation of Yes Associated Protein 1 Expression Reduces Cell Proliferation and Clonogenicity of Pancreatic Cancer Cells. PLoS ONE 7:3, pages e32783.
Crossref
Crossref
Raquel Urtasun, Maria U. Latasa, Maria I. Demartis, Stella Balzani, Saioa Goñi, Oihane Garcia-Irigoyen, Maria Elizalde, Maria Azcona, Rosa M. Pascale, Francesco Feo, Paulette Bioulac-Sage, Charles Balabaud, Jordi Muntané, Jesus Prieto, Carmen Berasain & Matias A. Avila. (2011) Connective tissue growth factor autocriny in human hepatocellular carcinoma: Oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation. Hepatology 54:6, pages 2149-2158.
Crossref
Crossref
Irena Ivanovska, Chunsheng Zhang, Angela M. Liu, Kwong F. Wong, Nikki P. Lee, Patrick Lewis, Ulrike Philippar, Dimple Bansal, Carolyn Buser, Martin Scott, Mao Mao, Ronnie T. P. Poon, Sheung Tat Fan, Michele A. Cleary, John M. Luk & Hongyue Dai. (2011) Gene Signatures Derived from a c-MET-Driven Liver Cancer Mouse Model Predict Survival of Patients with Hepatocellular Carcinoma. PLoS ONE 6:9, pages e24582.
Crossref
Crossref
Pei Wang, Yujie Bai, Bangrong Song, Yadong Wang, Dong Liu, Yongqiang Lai, Xiaolin Bi & Zengqiang Yuan. (2011) PP1A-Mediated Dephosphorylation Positively Regulates YAP2 Activity. PLoS ONE 6:9, pages e24288.
Crossref
Crossref
M Z Xu, S W Chan, A M Liu, K F Wong, S T Fan, J Chen, R T Poon, L Zender, S W Lowe, W Hong & J M Luk. (2010) AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene 30:10, pages 1229-1240.
Crossref
Crossref
Srikant Ambatipudi, Moritz Gerstung, Ravindra Gowda, Prathamesh Pai, Anita M. Borges, Alejandro A. Schäffer, Niko Beerenwinkel & Manoj B. Mahimkar. (2011) Genomic Profiling of Advanced-Stage Oral Cancers Reveals Chromosome 11q Alterations as Markers of Poor Clinical Outcome. PLoS ONE 6:2, pages e17250.
Crossref
Crossref
Li Jiang & Shinya Toyokuni. (2011) Elucidation of Asbestos-induced Mesothelial Carcinogenesis toward Its Prevention. Genes and Environment 33:1, pages 4-9.
Crossref
Crossref
Xuelian Luo. (2010) Snapshots of a hybrid transcription factor in the Hippo pathway. Protein & Cell 1:9, pages 811-819.
Crossref
Crossref